Functioning and disability in adults with myotonic dystrophy type 1

Disability and Rehabilitation

Volumn 33, Issue 19-20, 2011, Pages 1826-1836

  Kierkegaard, Marie ^a,b   Harms Ringdahl, Karin ^a,b   Holmqvist, Lotta Widén ^a,b   Tollbck, Anna ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Myotonic dystrophy type 1; neuromuscular diseases; participation; physical therapy

Indexed keywords

AGED; ARTICLE; CLASSIFICATION; CROSS-SECTIONAL STUDY; DAILY LIFE ACTIVITY; DISABILITY; DISABLED PERSON; DISEASE COURSE; FEMALE; HOSPITALIZATION; HUMAN; LIFESTYLE; MALE; MIDDLE AGED; MUSCLE; MYOTONIC DYSTROPHY; PATHOPHYSIOLOGY; PHYSIOLOGY; QUALITY OF LIFE; QUESTIONNAIRE; SOCIAL PARTICIPATION; STATISTICS; SWEDEN; WALKING;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; DISABLED PERSONS; DISEASE PROGRESSION; FEMALE; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; MUSCLES; MYOTONIC DYSTROPHY; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SOCIAL PARTICIPATION; SWEDEN; WALKING;

EID: 80052072230     PISSN: 09638288     EISSN: 14645165     Source Type: Journal    
DOI: 10.3109/09638288.2010.549287     Document Type: Article

References (59)

1. World Health Organization. International classification of functioning, disability and health: ICF. Geneva: WHO; 2001.
2. Harper PS. Myotonic dystrophy. 3rd ed. London: W.B. Saunders; 2001.
3. Mathieu J, Boivin H, Meunier D, Gaudreault M, Bégin P. Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy. Neurology 2001;56:336-340. (Pubitemid 32144144)
4. Gagnon C, Mathieu J, Noreau L. Life habits in myotonic dystrophy type 1. J Rehabil Med 2007;39:560-566. (Pubitemid 47455225)
5. Harper PS, van Engelen B, Eymard B, Wilcox DE, editors. Myotonic dystrophy: present management, future therapy. Oxford: Oxford University Press; 2004.
6. Nätterlund B, Gunnarsson L-G, Ahlström G. Disability, coping and quality of life in individuals with muscular dystrophy: a prospective study over five years. Disabil Rehabil 2000;22:776-785. (Pubitemid 32040840)
7. Nätterlund B, Ahlström G. Activities of daily living and quality of life in persons with muscular dystrophy. J Rehabil Med 2001;33:206-211. (Pubitemid 32834146)
8. Kierkegaard M, Harms-Ringdahl K, Widén Holmqvist L, Tollbäck A. Perceived functioning and disability in adults with myotonic dystrophy type 1: a survey according to the International Classification of Functioning, Disability and Health. J Rehabil Med 2009;41:512-520.
9. Mathieu J, De Braekeleer M, Prévost C, Boily C. Myotonic dystrophy: clinical assessment of muscular disability in an isolated population with presumed homogeneous mutation. Neurology 1992;42:203-208.
10. WHO. Obesity: preventing and managing the global epidemic. Report of aWHO Consultation.WHO Technical Report Series Geneva: World Health Organization; 2000.
11. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo,R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J. Standardisation of spirometry. Eur Respir J 2005;26:319-338. (Pubitemid 41079078)
12. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, MillerMR, Navajas D, Pedersen OF, Wanger J. Interpretative strategies for lung function tests. Eur Respir J 2005;26:948-968. (Pubitemid 41632054)
13. Astrand PO. Ergometric aerobic capacity test (Ergometri konditionsprov in Swedish). Varberg: Monark Exercise AB; 1964.
14. Andersson G, Forsberg A, Malmgren S. Aerobic capacity test on ergometercycle (Konditionstest pa° cykel in Swedish). Stockholm: SISU Idrottsbö cker; 1999.
15. Noonan V, Dean E. Submaximal exercise testing: clinical application and interpretation. Phys Ther 2000;80:782-807. (Pubitemid 30620609)
16. Mathiowetz V, Kashman N, Volland G, Weber K, Dowe M, Rogers S. Grip and pinch strength: normative data for adults. Arch Phys Med Rehabil 1985;66:69-74. (Pubitemid 15134048)
17. Mathiowetz V. Reliability and validity of grip and pinch strength measurements. Crit Rev Phys Rehabil 1991;2:201-212.
18. Mathiowetz V. Comparison of Rolyan and Jamar dynamometers for measuring grip strength. Occup Ther Int 2002;9:201-209. (Pubitemid 35276555)
19. Mathiowetz V, Weber K, Volland G, Kashman N. Reliability and validity of grip and pinch strength evaluations. J Hand Surg A 1984;9:222-226. (Pubitemid 14135263)
20. Aldehag AS, Jonsson H, Littorin S, Ansved T. Reliability of hand function testing instruments in patients with muscular dystrophies. Int J Ther Rehabil 2008;15:211-218.
21. Mathiowetz V, Weber K, Kashman N, Volland G. Adult norms for the nine hole peg test of finger dexterity. Occup Ther J Res 1985;5:24-38. (Pubitemid 16177999)
22. Svensson E, Hager-Ross C. Hand function in Charcot Marie Tooth: test retest reliability of some measurements. Clin Rehabil 2006;20:896-908. (Pubitemid 46940497)
23. Csuka M, McCarty DJ. Simple method for measurement of lower extremity muscle strenght. Am J Med 1985;78:77-81. (Pubitemid 15159622)
24. Newcomer KL, Krug HE, Mahowald ML. Validity and reliability of the timed-stands test for patients with rheumatoid arthritis and other chronic diseases. J Rheumatol 1993;20:21-27. (Pubitemid 23049177)
25. Butland RJA, Pang J, Gross ER, Woodcock AA, Geddes DM. Two-, six-and twelve minute walking test in respiratory disease. Br Med J 1982;284:1607-1608. (Pubitemid 12105148)
26. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-117.
27. Kierkegaard M, Tollbäck A. Reliability and feasibility of the six minute walk test in subjects with myotonic dystrophy. Neuromuscul Disord 2007;17:943-949. (Pubitemid 350148159)
28. Troosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J 1999;14:270-274. (Pubitemid 29461288)
29. Finch E, Brooks D, Stratford PW, Mayo NE. Physical rehabilitation outcome measures: a guide to enhanced clinical decision making. 2nd ed. Baltimore: Lippincott Williams & Wilkins; 2002. pp 248-251.
30. Tyson S, Connell L. The psychometric properties and clinical utility of measures of walking and mobility in neurological conditions: a systematic review. Clin Rehabil 2009;23:1018-1033.
31. Collen FM, Wade DT, Robb GF, Bradshaw CM. The Rivermead Mobility Index: a further development of the Rivermead Motor Assessment. Int Disabil Stud 1991;13:50-54.
32. van Engelen BG, Eymard B, Wilcox D. 123rd ENMC International Workshop: management and therapy in myotonic dystrophy, 6-8 February 2004, Naarden, The Netherlands. Neuromusc Disord 2005;15:389-394.
33. Sonn U, Hulter A° sberg K. Assessment of activities of daily living in the elderly. Scand J Rehabil Med 1991;23:193-202.
34. Sonn U. Longitudinal studies of dependence in daily life activities among elderly persons. Scand J Rehabil Med Suppl 1996;34:1-35.
35. Wade DT, Legh-Smith J, Langton Hewer R. Social activities after stroke: measurement and natural history using the Frenchay Activities Index. Int Rehabil Med 1985;7:171-181.
36. Turnbull JC, Kersten P, Habib M, McLellan L, Mullee MA, George S. Validation of the Frenchay Activities Index in a general population aged 16 years and older. Arch Phys Med Rehabil 2000;81:1034-1038. (Pubitemid 30618658)
37. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540-545.
38. Johns MW. Sensitivity and specificity of the multiple sleep latency test (MSLT), the maintenance of wakefulness test and the Epworth sleepiness scale: failure of the MSLT as a gold standard. J Sleep Res 2000;9:5-11. (Pubitemid 30195287)
39. Laberge L, Gagnon C, Jean S, Mathieu J. Fatigue and daytime sleepiness rating scales in myotonic dystrophy: a study of reliability. J Neurol Neurosurg Psychiatry 2005;76:1403-1405. (Pubitemid 41360980)
40. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989;46:1121-1123. (Pubitemid 19246303)
41. HRQL gruppen. Hospital Anxiety and Depression scale. 2009 [cited;101020]. Available from: http://www.hrql.se/content/frageformular/hospital-scale- default.asp.
42. Frändin K, Grimby G. Assessment of physical activity, fitness and performance in 76-years olds. Scand J Med Sci Sports 1994;4:41-46.
43. Kirkwood BR, Sterne JAC. Essential medical statistics. 2nd ed. Oxford: Blackwell Publishing Ltd.; 2003.
44. Akobeng AK. Understanding diagnostic tests 3: receiver operating characteristic curves. Acta Paediatr 2007;96:644-647. (Pubitemid 46653167)
45. McCrory MA, Kim H-R, Wright NC, Lovelady CA, Aitkens S, Kilmer DD. Energy expenditure, physical activity, and body composition of ambulatory adults with heriditary neuromuscular disease. Am J Clin Nutr 1998;67:1162-1169. (Pubitemid 28259503)
46. Aitkens S, Kilmer DD, Wright NC, McCrory MA. Metabolic syndrome in neuromuscular disease. Arch Phys Med Rehabil 2005;86:1030-1036. (Pubitemid 40692374)
47. Johansson A° . Immuno-endocrine abnormalities in myotonic dystrophy [Medical Dissertation]. Umea°: Umea° University; 2000.
48. Allebeck P, Backhans M, Greitz B, Heimerson I, Kark M. Public Health Report 2007. Stockholm: Stockholm Centre for Public Health; 2007.
49. Mathieu J, Allard P, Potvin L, Prevost C, Begin P. A 10-year study of mortality in a cohort of patients with myotonic dystrophy. Neurology 1999;52:1658-1662. (Pubitemid 29220644)
50. van der Kooi EL, Lindeman E, Riphagen I. Strength training and aerobic exercise training for muscle disease. Cochrane Database Syst Rev 2005;1:CD003907.
51. Dahlbom K, Ahlström G, Barany M, Kihlgren A, Gunnarsson L-G. Muscular dystrophy in adults: a five year follow up. Scand J Rehabil Med 1999;31:178-184.
52. Nitz J, Burke B. A study of the facilitation of respiration in myotonic dystrophy. Physiother Res Int 2002;7:228-238.
53. Ugalde V, Breslin EH, Walsh SA, Bonekat HW, Abresch RT, Carter GT. Pursed lips breathing improves ventilation in myotonic muscular dystrophy. Arch Phys Med Rehabil 2000;81:472-478. (Pubitemid 30192041)
54. Laberge L, Dauvilliers Y, Begin P, Richer L, Jean S, Mathieu J. Fatigue and daytime sleepiness in patients with myotonic dystrophy type 1: To lump or split? Neuromuscul Disord 2009;19:397-402.
55. Phillips MF, Steer HM, Soldan JR, Wiles CM, Harper PS. Daytime somnolence in myotonic dystrophy. J Neurol 1999;246:275-282. (Pubitemid 29229353)
56. Kalkman JS, Schillings ML, Zwarts MJ, van Engelen BG, Bleijenberg G. The development of a model of fatigue in neuromuscular disorders: a longitudinal study. J Psychosom Res 2007;62:571-579. (Pubitemid 46635469)
57. Winblad S, Lindberg C, Hansen S. Temperament and character in patients with classical myotonic dystrophy type 1 (DM-1). Neuromuscul Disord 2005;15:287-292. (Pubitemid 40431933)
58. Meola G, Sansone V. Cerebral involvment in myotonic dystrophies. Muscle Nerve 2007;36:294-306.
59. Schwartz CE. Applications of response shift theory and methods to participation measurement: a brief history of a young field. Arch Phys Med Rehabil 2010;91:S38-S43